Ciprofloxacin resistance in E. coli UTI is increasing. The use of this antimicrobial agent as empirical therapy for UTI should be reconsidered and efforts should be made to limit its use to ...

Outcomes analyzed were the frequency of febrile neutropenia, bacteremia, duration of antibiotic therapy and hospitalization, and antimicrobial resistance to ciprofloxacin and extended-spectrum ...

The use of prophylactic antibiotics is an option, but this raises concerns about the development of antibiotic resistance ... or one 500 mg oral dose of ciprofloxacin, 1 hour before undergoing ...

“Given together with cipro, DEQ reduced the development of mutations that confer antibiotic resistance, both in laboratory cultures and in animal models of infection, and bacteria did not ...

Antibiotic resistance is the ability of bacteria to resist the effects of antibiotics, a type of drug - such as penicillin or ciprofloxacin - that kills or stops the growth of bacteria. When bacteria ...

One antibiotic—ciprofloxacin—has been in active clinical use since 1987; the other—GP6—is experimental. The researchers found ...

Between 8% to 65% of E. coli associated with urinary tract infections presented resistance to ciprofloxacin, an antibiotic commonly used to treat this condition. “The report confirms the serious ...

With AMR deaths projected to exceed 10 million annually by 2050, a gender-sensitive, intersectional approach is critical to ...

A team of researchers has developed a microfluidic system to tackle antimicrobial resistance (AMR). Operating at the ...